Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.05) per share. The company reported quarterly sales of $7.84 million which missed the analyst consensus estimate of $8.21 million by 4.48 percent. This is a 34.05 percent increase over sales of $5.85 million the same period last year.
Posted In: BFRI